Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118933062 | 11893306 | 2 | F | 20000329 | 20160827 | 20160106 | 20160829 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10964161 | BRISTOL MYERS SQUIBB | 0.00 | DY | F | Y | 2.33000 | KG | 20160829 | CN | US | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118933062 | 11893306 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | 30 MG, BID | N | 20412 | 30 | MG | CAPSULE, HARD | BID | |||||
| 118933062 | 11893306 | 2 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | UNK | 122 | DF | U | 0 | |||||||
| 118933062 | 11893306 | 3 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | 2 TAB, QD | 122 | DF | U | 0 | 2 | DF | QD | ||||
| 118933062 | 11893306 | 4 | SS | VIRAMUNE | NEVIRAPINE | 1 | Transplacental | 200 MG, BID | U | 0 | 200 | MG | BID | ||||||
| 118933062 | 11893306 | 5 | SS | RETROVIR | ZIDOVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118933062 | 11893306 | 6 | SS | VIRACEPT | NELFINAVIR MESYLATE | 1 | Transplacental | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118933062 | 11893306 | 1 | Product used for unknown indication |
| 118933062 | 11893306 | 2 | Product used for unknown indication |
| 118933062 | 11893306 | 4 | Product used for unknown indication |
| 118933062 | 11893306 | 5 | Product used for unknown indication |
| 118933062 | 11893306 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118933062 | 11893306 | OT |
| 118933062 | 11893306 | DS |
| 118933062 | 11893306 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118933062 | 11893306 | Congenital musculoskeletal anomaly | |
| 118933062 | 11893306 | Foetal exposure during pregnancy | |
| 118933062 | 11893306 | Low birth weight baby |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118933062 | 11893306 | 1 | 19990709 | 19990907 | 0 | |
| 118933062 | 11893306 | 2 | 199903 | 199907 | 0 | |
| 118933062 | 11893306 | 3 | 19990709 | 19990907 | 0 | |
| 118933062 | 11893306 | 4 | 19990709 | 19990907 | 0 | |
| 118933062 | 11893306 | 5 | 199907 | 19990907 | 0 | |
| 118933062 | 11893306 | 6 | 199903 | 19990907 | 0 |